Evidence map›Paper›PMID 31145554›Full record

ArticleCurrent protocols in mouse biology2019

Ultrasound-Guided Approaches to Improve Orthotopic Mouse Xenograft Models for Hepatocellular Carcinoma.

Ghina Bou About, Emilie Thiebault, Marie Wattenhofer-Donzé, Hugues Jacobs, Alain Guimond, Tania Sorg, Eric Robinet, Thomas F Baumert, Laurent Monassier, Yann Herault

Open access · hybridAbstract read
In one paragraph

Article in Current protocols in mouse biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Ultrasound Guided Surgery as a Refinement Tool in Oncology Research.Animals : an open access journal from MDPI · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ghina Bou AboutInstitut Clinique de la Souris, PHENOMIN-ICS, Illkirch, France.
Emilie ThiebaultInstitut Clinique de la Souris, PHENOMIN-ICS, Illkirch, France.
Marie Wattenhofer-DonzéInstitut Clinique de la Souris, PHENOMIN-ICS, Illkirch, France.
Hugues JacobsInstitut Clinique de la Souris, PHENOMIN-ICS, Illkirch, France.
Alain GuimondInstitut Clinique de la Souris, PHENOMIN-ICS, Illkirch, France.
Tania SorgInstitut Clinique de la Souris, PHENOMIN-ICS, Illkirch, France.
Eric RobinetInstitute of Image-Guided Surgery, University of Strasbourg, Strasbourg, France.
Thomas F BaumertInstitute of Image-Guided Surgery, University of Strasbourg, Strasbourg, France.
Laurent MonassierInstitut Clinique de la Souris, PHENOMIN-ICS, Illkirch, France.
Yann HeraultInstitut Clinique de la Souris, PHENOMIN-ICS, Illkirch, France.
Institut Clinique de la Souris · FRInstitut de Chirurgie Guidée par l'Image · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRUniversité de Strasbourg · FR

Funding

Agence Nationale de la Recherche ANR-10-IDEX-0002-02Agence Nationale de la Recherche ANR-10-INBS-07 PHENOMINARC, Paris and Institut Hospitalo-Universitaire, Strasbourg TheraHCC IHUARC IHU201301187European Research Council 671231European Union Horizon 2020 research and innovation program 667273European Union Horizon 2020 research and innovation program 671231Foundation of the University of Strasbourg and Roche Institute (HEPKIN)French National Center for Scientific Research (CNRS)French National Institute of Health and Medical Research (INSERM)University of Strasbourg and Centres Européen de Recherche en Biologie et Médecine
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. While curative approaches for early stage HCC exist, effective treatment options for advanced HCC are lacking. Furthermore, there are no efficient chemopreventive strategies to limit HCC development once cirrhosis is established. One challenge for drug development is unsatisfactory animal models. In this article, we describe an orthotopic xenograft mouse model of human liver cancer cell lines through image-guided injection into the liver. This technique provides a less invasive yet highly efficient approach to engraft human HCC into mouse liver. Similarly, image-guided injections are used to deliver chemotherapeutics locally, enabling reduction in potential systemic adverse effects, while reducing the required dose for a therapeutic effect. In summary, this image-guided strategy provides a novel and convenient approach to improve current HCC mouse models. © 2019 The Authors. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Indexed as

MiceAnimalsCarcinoma, HepatocellularHeterograftsLiver NeoplasmsLiver Neoplasms, ExperimentalTransplantation, HeterologousUltrasonicsdoxorubicinechographyecho-guided injectionhepatocarcinomaHuh-7orthotopic

Identifiers

PMID31145554
PMCPMC7613417
OpenAlexW2947052309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.